www.fdanews.com/articles/63216-glaxo-seeks-european-ok-for-its-breast-cancer-drug
GLAXO SEEKS EUROPEAN OK FOR ITS BREAST CANCER DRUG
October 11, 2006
GlaxoSmithKline PLC said it is seeking regulatory approval to sell its breast cancer drug Tykerb -- one of the most promising high earners in its pipeline of new medicines -- in Europe. Boston Globe (http://www.boston.com/business/globe/articles/2006/10/10/glaxo_seeks_european_ok_for_its_breast_cancer_drug/)